Literature DB >> 29682623

Long-term adjuvant treatment of gastrointestinal stromal tumors (GIST) with imatinib-a comment and reflection on the PERSIST-5 study.

Silke Cameron1.   

Abstract

Entities:  

Year:  2018        PMID： 29682623      PMCID： PMC5897665          DOI： 10.21037/tgh.2018.03.01

Source DB:  PubMed          Journal:  Transl Gastroenterol Hepatol        ISSN： 2415-1289


× No keyword cloud information.
  22 in total

1.  Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor.

Authors:  H Joensuu; P J Roberts; M Sarlomo-Rikala; L C Andersson; P Tervahartiala; D Tuveson; S Silberman; R Capdeville; S Dimitrijevic; B Druker; G D Demetri
Journal:  N Engl J Med       Date:  2001-04-05       Impact factor: 91.245

2.  ST1571: a paradigm for clinical trials of molecularly targeted agents.

Authors:  B J Druker
Journal:  Biomed Pharmacother       Date:  2001-11       Impact factor: 6.529

3.  Long-term results of adjuvant imatinib mesylate in localized, high-risk, primary gastrointestinal stromal tumor: ACOSOG Z9000 (Alliance) intergroup phase 2 trial.

Authors:  Ronald P DeMatteo; Karla V Ballman; Cristina R Antonescu; Christopher Corless; Violetta Kolesnikova; Margaret von Mehren; Martin D McCarter; Jeffrey Norton; Robert G Maki; Peter W T Pisters; George D Demetri; Murray F Brennan; Kouros Owzar
Journal:  Ann Surg       Date:  2013-09       Impact factor: 12.969

4.  Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI stromal tumor: the ACOSOG Z9001 trial.

Authors:  Christopher L Corless; Karla V Ballman; Cristina R Antonescu; Violetta Kolesnikova; Robert G Maki; Peter W T Pisters; Martin E Blackstein; Charles D Blanke; George D Demetri; Michael C Heinrich; Margaret von Mehren; Shreyaskumar Patel; Martin D McCarter; Kouros Owzar; Ronald P DeMatteo
Journal:  J Clin Oncol       Date:  2014-03-17       Impact factor: 44.544

5.  Immune cells in primary and metastatic gastrointestinal stromal tumors (GIST).

Authors:  Silke Cameron; Marieke Gieselmann; Martina Blaschke; Giuliano Ramadori; Laszlo Füzesi
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

6.  Impact of serosal involvement/extramural growth on the risk of synchronous and metachronous peritoneal spread in gastrointestinal stromal tumors: proposal for a macroscopic classification of GIST.

Authors:  Abbas Agaimy; Nikolaos Vassos; Peter H Wunsch; Werner Hohenberger; Arndt Hartmann; Roland S Croner
Journal:  Int J Clin Exp Pathol       Date:  2012-01-01

Review 7.  Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts.

Authors:  Heikki Joensuu; Aki Vehtari; Jaakko Riihimäki; Toshirou Nishida; Sonja E Steigen; Peter Brabec; Lukas Plank; Bengt Nilsson; Claudia Cirilli; Chiara Braconi; Andrea Bordoni; Magnus K Magnusson; Zdenek Linke; Jozef Sufliarsky; Massimo Federico; Jon G Jonasson; Angelo Paolo Dei Tos; Piotr Rutkowski
Journal:  Lancet Oncol       Date:  2011-12-06       Impact factor: 41.316

Review 8.  Chronic myelogenous leukemia: update on biology and treatment.

Authors:  Stefan Faderl; Hagop M Kantarjian; Moshe Talpaz
Journal:  Oncology (Williston Park)       Date:  1999-02       Impact factor: 2.990

Review 9.  Diagnosis of gastrointestinal stromal tumors: A consensus approach.

Authors:  Christopher D M Fletcher; Jules J Berman; Christopher Corless; Fred Gorstein; Jerzy Lasota; B Jack Longley; Markku Miettinen; Timothy J O'Leary; Helen Remotti; Brian P Rubin; Barry Shmookler; Leslie H Sobin; Sharon W Weiss
Journal:  Hum Pathol       Date:  2002-05       Impact factor: 3.466

10.  Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinib.

Authors:  Heikki Joensuu; Mikael Eriksson; Kirsten Sundby Hall; Jörg T Hartmann; Daniel Pink; Jochen Schütte; Giuliano Ramadori; Peter Hohenberger; Justus Duyster; Salah-Eddin Al-Batran; Marcus Schlemmer; Sebastian Bauer; Eva Wardelmann; Maarit Sarlomo-Rikala; Bengt Nilsson; Harri Sihto; Karla V Ballman; Mika Leinonen; Ronald P DeMatteo; Peter Reichardt
Journal:  Cancer       Date:  2014-04-15       Impact factor: 6.860
View more
  3 in total

1.  Long-term adjuvant imatinib treatment for a patient who underwent complete resection of a localized recurrent gastrointestinal stromal tumor after preoperative imatinib treatment: A case report.

Authors:  Welda E H Tjhoi; Kai Li; Chun-Hui Shou; Wei-Li Yang; Ji-Ren Yu
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

2.  Pelvic Gastrointestinal Stromal Tumor With Pulmonary Metastasis.

Authors:  Shalaka Akolkar; Constantine Melitas; Marc Piper
Journal:  ACG Case Rep J       Date:  2019-08-29

3.  Gigantic GIST: A Case of the Largest Gastrointestinal Stromal Tumor Found to Date.

Authors:  Abdalla Mohamed; Youssef Botros; Paul Hanna; Sang Lee; Walid Baddoura; Jamshed Zuberi; Tanuja Damani
Journal:  Case Rep Surg       Date:  2018-09-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.